Friday, 24 July 2015

FDA approves Sanofi/Regeneron cholesterol drug with limits

ReutersFDA approves Sanofi/Regeneron cholesterol drug with limitsReutersWASHINGTON The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those ...FDA approves new cholesterol lowering drugCNNFDA approves new cholesterol drug that may lead to fewer heart attacks, strokesWashington PostThe FDA Approves A Potent And Pricey Cholesterol-Lowering ShotForbesBloomberg -Wall Street Journal -NBCNews.comall 118 news articles »

No comments:

Post a Comment